| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 22, 2021 | Post-IPO Equity | $45M | — | — | — | Detail |
| Apr 16, 2021 | Post-IPO Equity | $30M | — | — | — | Detail |
| Jun 12, 2019 | Post-IPO Equity | $80M | 1 | Ginkgo Bioworks | — | Detail |
| Jan 23, 2018 | Post-IPO Equity | $50.01M | — | — | — | Detail |
| Aug 28, 2017 | IPO | — | — | — | — | Detail |
| May 16, 2017 | Series C | $42M | 11 | — | — | Detail |
| Feb 17, 2016 | Series B | $40M | 4 | OrbiMed | — | Detail |
| Oct 7, 2014 | Series A | $5M | 3 | Bill & Melinda Gates Foundation | — | Detail |
| Jul 22, 2014 | Series A | $29.40M | 2 | Atlas Venture , New Enterprise Associates | — | Detail |